Steven M. Paul, Director at Sage Therapeutics, Inc. (SAGE), sold 342,603 shares at $161.37 ($16.2M) on 2019-02-19, disclosed to the SEC on 2019-02-20.
Open-market sale of $16.2M SAGE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 241,695 | $0 | 0.0% |
| 2 | $161.02 | 12,044 | $1.9M | 11.9% |
| 3 | $161.02 | 12,044 | $1.9M | 11.9% |
| 4 | $161.02 | 12,388 | $2.0M | 12.3% |
| 5 | $161.02 | 12,388 | $2.0M | 12.3% |
| 6 | $161.02 | 12,510 |
| $2.0M |
| 12.4% |
| 7 | $161.02 | 12,519 | $2.0M | 12.4% |
| 8 | $161.02 | 12,519 | $2.0M | 12.4% |
| 9 | $161.02 | 12,510 | $2.0M | 12.4% |
| 10 | $161.37 | 643 | $104K | 0.6% |
| 11 | $161.37 | 643 | $104K | 0.6% |
| 12 | $161.62 | 500 | $81K | 0.5% |
| 13 | $162.00 | 200 | $32K | 0.2% |
| Total | $47.43 avg | 342,603 | $16.2M | 100% |
| Filing → |
| KRTX | BUY | 2021-08-18 | $501K | — | Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |